Intracoronary eptifibatide with vasodilators to prevent no-reflow in diabetic STEMI with high thrombus burden. A randomized trial

2022 ◽  
Author(s):  
Mohamed Hamza ◽  
Islam Y. Elgendy
Keyword(s):  
Randomized Trial ◽  
No Reflow

Randomized trial of intracoronary adenosine as adjunctive therapy for prevention of the no-reflow phenomenon

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Nima Naghshtabrizi ◽  
Manijeh Sajedi ◽  
Behshad Naghshtabrizi ◽  
Azadeh Mozayanimonfared ◽  
Mohamad Ali Seif Rabiei ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Adjunctive Therapy ◽  
No Reflow ◽  
No Reflow Phenomenon
Sign in / Sign up

Export Citation Format

Share Document